Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criterion 11. See AWMSG criteria for appraising a medicine for information. |
|
Medicine details |
|
Medicine name | insulin aspart Sanofi (Trurapi®) |
Formulation | 100 units/ml solution for injection (cartridge and pre-filled pen) |
Reference number | 4858 |
Indication | Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above |
Company | Sanofi |
BNF chapter | Endocrine system |
Submission type | N/A |
Status | Medicine does not meet criteria for AWMSG assessment |
Date of issue | 17/02/2021 |